Thermo Fisher Scientific Inc (TMO)

Financial leverage ratio

Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Total assets US$ in thousands 110,343,000 103,020,000 101,230,000 99,041,000 97,321,000 100,364,000 98,496,000 97,095,000 98,726,000 97,057,000 94,105,000 94,658,000 97,154,000 90,536,000 90,579,000 92,747,000 95,123,000 73,600,000 67,698,000 65,931,000
Total stockholders’ equity US$ in thousands 53,415,000 51,024,000 50,511,000 49,390,000 49,584,000 48,992,000 47,432,000 45,516,000 46,735,000 45,328,000 43,752,000 42,257,000 43,978,000 43,549,000 42,293,000 40,956,000 40,793,000 38,710,000 36,854,000 35,058,000
Financial leverage ratio 2.07 2.02 2.00 2.01 1.96 2.05 2.08 2.13 2.11 2.14 2.15 2.24 2.21 2.08 2.14 2.26 2.33 1.90 1.84 1.88

December 31, 2025 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $110,343,000K ÷ $53,415,000K
= 2.07


Peer comparison

Dec 31, 2025

Company name
Symbol
Financial leverage ratio
Thermo Fisher Scientific Inc
TMO
2.07
Agilent Technologies Inc
A
1.89
Danaher Corporation
DHR
1.59

See also:

Thermo Fisher Scientific Inc Financial Leverage (Quarterly Data)